Insights into the pharmacokinetics and pharmacodynamics of irinotecan
- PMID: 10999719
Insights into the pharmacokinetics and pharmacodynamics of irinotecan
Comment on
-
Factors involved in prolongation of the terminal disposition phase of SN-38: clinical and experimental studies.Clin Cancer Res. 2000 Sep;6(9):3451-8. Clin Cancer Res. 2000. PMID: 10999728